Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DIM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111747919B reveals a one-step catalytic route for benzofuran intermediates, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Patent CN111269094A details a novel lithiation-bromination route for 2-bromo-1,3-dimethoxybenzene, offering >99.9% purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN116874382B reveals a Cu-zeolite catalytic route for neostigmine intermediates. This method ensures high purity and scalable supply chain reliability.
Patent CN110343056A reveals a cost-effective three-step synthesis route. This method ensures high purity and supply chain reliability for pharmaceutical intermediates.
Patent CN111533662B details a cost-effective synthesis of citalopram intermediates using accessible halogenated benzoic acids, offering significant supply chain advantages.
Patent CN118241230B reveals advanced Kolbe electrolysis for musk ketone precursors. Achieve higher yield and selectivity with optimized electrochemical synthesis.
Novel catalytic synthesis for high-purity 2-amino-4,6-dimethoxypyrimidine. Reduces energy consumption and improves supply chain reliability for herbicide manufacturers.
Novel solvent-free chloromethylation route for 2,6-dimethyl-tyrosine reduces costs and improves scalability for pharmaceutical intermediate manufacturing.
Patent CN102285935A details a high-yield synthesis of OXD-7, an organic electroluminescent material. This report analyzes the improved cyclodehydration process for cost-effective manufacturing.
Patent CN104926674A reveals a selective synthesis route for Z-unsaturated amides. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced synthesis of pazopanib hydrochloride intermediates via safe reductive amination. Cost-effective, scalable routes for API manufacturing supply chains.
Patent CN113999160B reveals a safer, cost-effective route for antiviral intermediates. Discover how this novel method reduces supply chain risks and manufacturing costs significantly.
Patent CN101823941A details a catalyst-free, water-based chlorination process for PCMX, offering significant cost reduction and environmental compliance for disinfectant manufacturing.
Patent CN102249937A details a low-cost, non-toxic synthesis for Ivabradine intermediates, offering significant supply chain advantages for API manufacturers.
New patent CN116715573B reveals high-yield synthesis route for 2 2-dimethylbutyryl chloride offering significant purity improvements and supply chain stability for pharmaceutical manufacturers.
Novel water/ethanol synthesis of 5-(aryl methylene) Michaelis acid. High yield, eco-friendly, scalable process for pharmaceutical intermediates.
Novel dimethylchlorosilane activation method for Tegafur ensures 99.9% purity and mild conditions. Ideal for reliable API intermediate suppliers seeking cost reduction.
Patent CN114605308A details a scalable synthesis of 6,6-dimethyl-3-azabicyclo[3.1.0]hexane using dihalo-acyl chloride cyclization, offering significant cost and safety advantages.
Patent CN106045830B reveals a green synthesis route for metconazole intermediates, eliminating toxic methyl bromide and ensuring high purity for agrochemical manufacturing.
Patent CN108059599B reveals a cost-effective route for Venetoclax intermediates. Discover how this novel one-pot method reduces production costs and ensures high purity.